Two protein expression vectors have been designed for the preparation of NMR samples. The vectors encode the immunoglobulin-binding domain of streptococcal protein G (GB1 domain) linked to the N-terminus of the desired proteins. This fusion strategy takes advantage of the small size, stable fold, and high bacterial expression capability of the GB 1 domain to allow direct NMR spectroscopic analysis of the fusion protein by ' H-l5N correlation spectroscopy.
before one emerges that exhibits the desired spectral qualities. Current methods of NMR sample screening require a significant experimental commitment and are both labor and time intensive, specifically, subcloning, optimization of bacterial expression, protein purification, and complex formation have to be performed (Clubb et al., 1994; Werner et al., 1995; Huth et al., 1997; Omichinski et al., 1997) . Frequently, a refolding procedure may also be required (Huth et al., 1994; Werner et al., 1994) and, to obtain concentrated samples (1 mM), several buffer conditions have to be evaluated. With these factors in mind, we have developed two T7 RNA polymerase-based (Studier & Moffatt, 1986 ) expression vectors that are tailored specifically for NMR sample preparation and screening. In the strategy described here, the engineered protein is synthesized as a fusion with the B1 immunoglobulin binding domain of streptococcal protein G (GB]; 56 residues) (Gronenborn et al., 1991) . As is true for other N-terminal fusion proteins, such as those containing domains from glutathione S-transferase (Smith & Johnson, 1988) , maltose binding protein (di Guan et al., 1988) , protein A (Nilsson et al., 1985; Jansson et al., 1996) , or thioredoxin (LaVallie et al., 1993) , the presence of the GB1 domain results in very high expression levels of the fusion protein and limits the need to optimize expression conditions. For most fusion proteinbased expression strategies, the N-terminal domain is rather large and is removed by proteolysis prior to NMR analysis. This com-plicates the screening procedure because protocols for digestion and purification of the cleaved products can vary depending on the sample. In the case of the GB1 expression system, we show that, owing to the small size of GB I , it is readily possible to perform the spectroscopic analysis on the GB I fusion proteins. Using this approach, we demonstrate that one can overexpress, purify, and acquire a 'H-'sN correlation spectrum of a labeled protein in several days, and thus rapidly evaluate its solubility, stability, and binding characteristics.
Results and discussion
The design of the GB1 fusion protein expression vectors is outlined in Figure I . The first vector (GEVI) encodes a noncleavable linker between the GB1 domain and the desired protein, whereas the second vector (GEV2) contains a thrombin-cleavable linker as well as several more 3' cloning sites. Both vectors encode an optional poly His-tag at the C terminus of the fusion protein to allow purification using Ni" affinity chromatography under nondenaturing conditions.
On its own, the GB1 domain expresses at very high levels in Escherichia coli and -3 pmol of "N-labeled protein can be pu- 
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rified from a 100-mL culture in minimal medium (A.M. Gronenborn, unpubl. results). We have found that GB1 fusion proteins also express at high levels such that 0.1-I-L cultures are typically grown for sample screening. Figure 2 shows an SDS-PAGE analysis of GB1 fusions with either the activation domain of yeast GCN4 (residues 39-139) (Jackson et al., 1996) or the death domain of FAS (residues 210-304) (Suda et al., 1993) . The GBI-GCN4 fusion protein was purified by Ni'+ affinity chromatography, whereas the GBI-Fas fusion protein was purified by affinity chromatography using IgG-sepharose. In both cases, a single-step procedure yielded 80-90% pure protein, sufficient for analysis by 2D 'H-l5N correlation spectroscopy. In fact, purification may not be required for the initial screening because direct analysis of a 'H-I5N correlation spectrum recorded on whole-cell extracts, after removal of the cell debris, is possible for small-to medium-sized (up to -20 kDa) soluble proteins (Gronenborn & Clore, 1996) . The I H-IsN correlation spectra of the GB I -GCN4 and GB 1 -Fas fusion proteins are presented in Figures 3 and 4 , respectively, and demonstrate the simplicity of this approach for evaluating the stability and solubility of these proteins. A qualitative assessment of the spectra permits the presence of regular secondary structure elements to be evaluated on the basis of the chemical-shift dispersion of backbone and side-chain amide groups. Random coil amide protons typically resonate between 7.8 and 8.4 ppm, whereas the chemical shifts of hydrogen bonded amides in P-sheets and a-helices frequently lie outside of this region. Because of its small size, the GB1 fusion domain does not interfere significantly with the detection of amide chemical shifts of the expressed partner protein, but rather, acts as an internal control for sample preparation and instrument operation. Note that, with the exception of the crowded, random-coil region between 7.8 and 8.4 ppm, all the GB1 signals in the GBI-GCN4 fusion protein are easily assigned in the 2D lH-15N correlation spectrum by comparison with assignments reported previously (Barchi et al., 1994) . A 3D "N-edited NOE spectrum of a GB 1-HMG-I fusion supports these assignments (data not shown). Simple inspection of the remainder of the GBl-GCN4 spectrum (Fig. 3) indicates that the activation domain of GCN4 contains little, if any, stable secondary structure, and, therefore, is in all likelihood unfolded. Apart from the sole tryptophan indole NH at 10.0 ppm and the side-chain amide protons (shown in red), only two resonances from GCN4 lie outside of the random coil region of the spectrum, albeit very close to the border. Further, the dispersion of side-chain amide protons from the three glutamine and four asparagine residues is very poor, also suggesting a random coil conformation. Thus, this simple screen indicates that the GCN4 activation domain requires more amino acids or, more likely, its binding partner for stabilization of the folded structure. On the other hand, the IH-I5N correlation spectrum of the GB1-Fas death domain fusion protein (Fig. 4) indicates that the domain comprising amino acids 210-304 of Fas is indeed folded. Eighteen signals between 6.9 and 7.8 ppm and three signals downfield of 8.4 ppm were observed, and the side-chain amide proton resonances are dispersed. The difficulty with this sample is due to aggregation, as evidenced by line broadening of both Fas and GB1 amide resonances (cf. the GB1 signals in Figs. 3 and 4) . From the two examples presented above, the screening process immediately suggests the appropriate course of action for optimizing the N M R samples. In the case of the activation domain of GCN4, this requires the difficult task of obtaining a complex consisting of the fusion protein and the interacting domain from a target or identifying the limits of a domain that maintains a stable fold. In the case of Fas, either solubility conditions would need to be explored for an already folded domain or the boundaries of the domain would have to be extended slightly to enhance solubility. The recent publication of the solution structure of the Fas death domain (Huang et al., 1996) confirms our results presented above, namely that residues 210-305 do indeed delineate the folded domain. However, the construct employed by Huang et al. (1996) was slightly longer, comprising residues 202-3 19, which presumably increased its solubility. In addition, the structure of the Fas death domain was determined at pH 4.0 in 50 mM sodium acetate and 50 mM NaCl, which may also have enhanced the solubility, whereas our spectrum was recorded in the absence of any salt at pH 4.3.
The application of the GB1-fusion strategy for exploring conditions for the formation of a peptide-DNA complex demonstrates another strength of this approach. Figure 5 illustrates an experiment to evaluate the binding of a 25-residue peptide to a target DNA site. In this case, the second DNA-binding domain (DBD2, residues 50-75) of HMG-I as the GB 1 fusion was "N-labeled and purified by IgG-sepharose affinity chromatography (-2 pmol/L culture). As is evident from the spectrum of the GB1-HMG-I fusion protein alone, only GB 1 resonances are detected outside of the random coil region of the IH-I5N correlation spectrum (Fig. 5A ). Upon addition, however, of the DNA dodecamer comprising the PRDII region of the interferon+ gene enhancer (Thanos & Maniatis, 1992 ; Fig. 5B ). HMG-I amide resonances appear outside of the random coil region at positions previously assigned for a larger HMG-I/DNA complex (Huth et al., 1997) . Interestingly, GB 1 resonances are not changed significantly, indicating that the GB1 portion of the fusion protein does not interact with the DNA. From these data, it is evident that the HMG-I DBD2 binds on its own to the PRDII target site, that the complex is not in intermediate exchange, and that the structure of HMG-I DBD2 bound to this DNA dodecamer could be solved by NMR.
In summary, the GB 1 fusion approach presented here represents a valuable tool for evaluating potential structural projects by NMR spectroscopy. Because the GB1 fusion domain does not, in any significant manner, interfere with substrate binding, this approach may be particularly useful for initial evaluations of protein-DNA, protein-protein, or protein-drug complexes. The advantages of the GB1 expression system, as well as the ability to label peptides with I5N as GB 1 fusions, facilitates the application of N M R in mapping macromolecular interactions. For example, a series of "N-labeled GB1-peptides spanning the sequence of a protein ligand could be prepared using the GEV expression vectors. Analysis of the 'H-15N correlation spectra of these labeled fusion peptides in the -I (50-75) are colored in red and in B are assigned based on previous assignments of an HMG-I(50-91)/DNA complex using the same DNA dodecamer (Huth et al., 1997) . Resonances corresponding to the side-chain amino protons of Asn 66 for both DNA-free and bound GBI-HMG-I (50-75) are labeled by lowercase letters. Note that the chemical-shift changes for the Asn 66 side-chain amino protons are indicative of the interaction of this functional group with the DNA. Note that the two cross-peaks at 10.2-10.4 ppm in the 'H dimension are folded in the 15N dimension and arise from W43(NG) and F52( NH) of GB 1. presence and absence of unlabeled receptor would detect those amino acids of the ligand that contact the receptor without prior knowledge of the ligand three-dimensional structure.
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Materials and methods
Preparation of the protein G fusion expression vectors (GEV and GEV2)
Coding sequences for the IgG binding domain of protein G with the amino acid changes T2Q, which eliminates methionine heterogeneity at the N-terminus from bacterial expression, and 16A (Smith et al., 1994) was PCR amplified using the primers 5"ATAATT AAACATATGCAGTACAAGCTTGCT (primer 1) and 5'-GCTAG were diluted fourfold with minimal medium that lacked glucose CCGGACCGCCCGGTTCGGTTACCGTGAAGGT (primer 2) to and yeast extract, shaken at 37 "C for 30 min, supplemented with create sequences encoding GB1 fused to the protease-resistant linker glucose, and induced with 1 mM IPTG, and grown for 4 h more at Pro-Gly-Gly-Pro-Ala-Ser. In a second PCR reaction, this linker 37°C prior to harvesting. was encoded on the 5' end of the sequence for huBC12 using the primers 5'-CCGGGCGGTCCGGCTAGCGCGCTCAG CCCTGTGCCA (primer 3) and 5"AATAAACTCGAGTTACTT TTTTCGCATGCTGGGGCCATATAG (primer 4). These PCR products were mixed and used as a template to amplify the sequence for the GBl-linker-BC12(82-204) using primers 1 and 4 in a third PCR reaction. The final PCR product was then cloned into pET2la (Novagen) using Nde I and Xho I cloning sites. The same strategy was used to prepare the GEV2 vector. Here the sequence for the GB1 domain was fused to the thrombin-cleavable linker Leu-Val-Pro-Arg-Gly-Ser using primer 1 and 5"GGATCCACGC GGAACCAGTTCGGTTACCGTGAAGGT (primer 5). The initial insert for placement between the peptide linker and the C-terminal His-tag consisted of the coding sequence for residues 131-259 of the SV40 large T-antigen (IgT) and was amplified using 5'-CTG GTTCCGCGTGGATCCAAGGTAGAAGACCCCAAGGACTTT (primer 6) and 5'-CGTCA-GGAATTCTTAAGGATTAAAATCAT GCTCCTTTAA (primer 7). The GB I-linker2-IgT( 13 1-259) fragment was amplified with primers 1 and 7 and cloned into pET2la using Nde I and EcoR I restriction sites.
Preparation of GCN4, Fas, and HMG-I expression vectors DNA encoding residues 39-139 of GCN4 from yeast Saccharomyces cerevisiae was amplified by PCR using the primers 5'-TCTACTGCCAAACCAAGATCTATGGTTGGCCAATTG and ATC and cloned into the BamH I and Xho I sites of GEV2 using Bgl I1 to create a compatible end for the BamH I site. DNA encoding residues 210-304 of human Fas (the death domain) was PCR amplified using the primers 5"GCGGGATCCGATGTTGA CTTGAGTAAA and 5'-CGTCCTCTCGAGTTAACTAGTAATG TCCTTGAG and cloned into GEV2 (Fig. I ) using 5' BamH I and 3' Xho I sites, removing the IgT insert. A stop codon was introduced to prevent the addition of the poly-His sequence at the C-terminus. DNA for amino acids 50-91 of human HMG-I and a stop codon was amplified using the primers 5"GCTCGTGGAT CCGAAGTGCCAACACCTAAG and 5"CTGGCTGAATTCTT AGGTTTTCCGGGTCTTGGC and cloned into GEV2 (Fig. 1 ) using 5' BamH I and 3' EcoR I sites.
5"GGATTCAATTGCCTTCTCGAGATCAGCCAATGAAAC
Expression and '"N-labeling of fusion proteins BLZl(DE3) cells (Novagen) were transformed with the respective vectors and grown to saturation (ODboo -4) in LB medium that contained 50 pg/mL ampicillin. Cultures were diluted fourfold with medium, shaken for IO min at 37 "C, and then induced with 1 mM isopropyl P-D-thiogalactoside (IPTG) for 4 h. To determine the extent of soluble expression, 100-mL cultures were pelleted, opened in a French pressure cell, cleared by centrifugation, and analyzed by SDS-PAGE using the Phast-Kast electrophoresis system (Pharmacia). For I5N labeling, glycerol stocks of cells in LB medium were grown in minimal medium with I. I g 15N-ammonium chloride as the nitrogen source, 5 g glucose, and 25 p L of a 10% solution of yeast extract per liter of culture. Glycerol stocks were prepared from this growth and used to inoculate cultures that were grown in minimal medium for 14 h to ODbo0 3.5-4. These cultures Purification of fusion proteins BL21 (DE3) cells that expressed GB 1-Fas or GB 1-HMG-I were broken in a French pressure cell in 50 mM Tris, pH 7.5, 5 mM EDTA, and 5 mM benzamidine. After brief sonication and centrifugation, the supernatant was filtered through a 0.45-pm membrane prior to loading onto a 20-mL IgG sepharose-fast flow column (Pharmacia), equilibrated in 50 mM Tris, pH 7.5, 150 mM NaCI. The column was washed with 50 mM Tris, pH 7.5, followed by 5 mM sodium acetate buffer, pH 5.0, and proteins were eluted in 0.5 M sodium acetate, pH 3.5. Proteins were concentrated by Amicon filtration, dialyzed against water, and further concentrated. NMR samples of GBI-HMG-I were concentrated to 1.2 mM in 10 mM sodium phosphate, pH 6.1,90% H20/10% D20. The GB 1 -Fas sample was concentrated to " 1 mM in 90% H20/10% D20, pH 4.3. GBI-GCN4 was purified by Ni2+ affinity chromatography (Pharmacia) according to the manufacturer's instructions, dialyzed against water, and concentrated to -1 mM using centricon-3 microconcentrators (Amicon) in 90% H20/10% D20, pH 6.2.
NMR spectroscopy
NMR experiments were performed on Bruker DMX600 and DMX750 spectrometers equipped with x,y,z-shielded gradient triple resonance probes. Spectra were processed with the NmrPipe package (Delaglio et al., 1995) and analyzed using the program PIPP (Garrett et al., 1991) . The 'H-"N HSQC spectra (Bax et al., 1990; Piotto et al., 1992) were recorded with 128* X 512* complex points in the indirect ("N) and acquisition ('H) dimensions, respectively. Details of the spectroscopy are provided in the figure legends.
